December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 23, 2024

Hormone Combo Linked to Autoimmune Risk

Combination hormone therapy was associated with higher risk for a range of autoimmune conditions in a recent study.

Conexiant

December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 18, 2024

Physicians With Kids Face Large Pay Gaps

Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.

Conexiant

December 16, 2024

Arthritis Drugs Linked to Fracture Risk

Current gabapentinoid use in patients with inflammatory arthritis was associated with a 36% higher odds of fractures compared to remote use, with risks persisting across most dose levels and showing marked impact shortly after drug initiation.

Conexiant

December 10, 2024

ASCVD Risk Elevated in Cutaneous Lupus

Recent study in JAMA Dermatology shows patients with cutaneous lupus erythematosus have a 72% higher risk of developing atherosclerotic cardiovascular disease, emphasizing the need for targeted screening and management.

Conexiant

December 10, 2024

Biomarkers in Familial Mediterranean Fever: Therapy Insights

A recent study on familial Mediterranean fever revealed that nearly 56% of heterozygous patients who stopped colchicine therapy sustained remission with lower levels of specific biomarkers, highlighting the potential of personalized treatment for FMF patients.

Conexiant

December 06, 2024

Endometriosis Pain: Two Key Phenotypes Identified

A recent study identified two distinct pain phenotypes in patients with endometriosis, revealing significant differences in symptom severity, comorbidities, and quality of life.

Conexiant

December 06, 2024

Experts Set First Global CNO Treatment Guidelines

An international expert panel introduces the first consensus recommendations for diagnosing and treating chronic non-bacterial osteitis (CNO) in adults - consolidating multiple disease labels into a single entity and establishing evidence-based protocols.

Conexiant